MTOR and cholangiocarcinoma: The collective evidence of genetic studies in CCA has suggested that mTOR plays a central and critical role in invasive CCA, and therefore, targeting the mTOR pathway with mTOR inhibitors could be envisioned as a novel treatment [20].